World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
38142
World Ranking
18245
National Ranking
1657

Overview

Keith G. Oldroyd is affiliated with the Golden Jubilee National Hospital in the United Kingdom. Their research primarily focuses on medicine, with a significant emphasis on cardiology and cardiovascular medicine.

They have published extensively in the subfields of cardiology and cardiovascular medicine, surgery, radiology, nuclear medicine and imaging, biomedical engineering, and emergency medicine. Their main topics of work include coronary interventions and diagnostics, cardiac imaging and diagnostics, acute myocardial infarction research, antiplatelet therapy and cardiovascular diseases, cardiovascular function and risk factors, cardiac arrest and resuscitation, and mechanical circulatory support devices.

Their recent papers cover important areas in cardiovascular medicine, including:

  • Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery, 2021, New England Journal of Medicine
  • Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction, 2021, JAMA Cardiology
  • Ticagrelor With or Without Aspirin After Complex PCI, 2020, Journal of the American College of Cardiology
  • Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS, 2020, European Heart Journal
  • Post-stenting fractional flow reserve vs coronary angiography for optimization of percutaneous coronary intervention (TARGET-FFR), 2021, European Heart Journal

Their frequent co-authors include:

  • Colin Berry (34 collaborative works)
  • Margaret McEntegart (25 collaborative works)
  • Hany Eteiba (20 collaborative works)
  • Peter McCartney (19 collaborative works)
  • Richard Good (19 collaborative works)

Keith G. Oldroyd's publications appear regularly in these venues:

  • Journal of the American College of Cardiology (16 publications)
  • JACC: Cardiovascular Interventions (13 publications)
  • European Heart Journal (8 publications)
  • EuroIntervention (6 publications)
  • Circulation Cardiovascular Interventions (5 publications)

Best Publications

  • Fractional flow reserve versus angiography for guiding percutaneous coronary intervention

    Bernard De Bruyne;Uwe Siebert;Fumiaki Ikeno;Volker Klauss

  • Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease

    Bernard De Bruyne;Bindu Kalesan;Emanuele Barbato;Zsolt Piroth

  • Fractional Flow Reserve Versus Angiography for Guiding Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease: 2-Year Follow-Up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Study

    Nico H.J. Pijls;William F. Fearon;Pim A.L. Tonino;Uwe Siebert;Uwe Siebert

  • Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation

    Pim A.L. Tonino;William F. Fearon;Bernard De Bruyne;Keith G. Oldroyd

  • Randomized trial of preventive angioplasty in myocardial infarction.

    David S. Wald;Joan K. Morris;Nicholas J. Wald;Alexander J. Chase

  • Fractional Flow Reserve–Guided PCI for Stable Coronary Artery Disease

    Bernard De Bruyne;William F. Fearon;Nico H.J. Pijls;Emanuele Barbato

  • PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock

    Holger Thiele;Ibrahim Akin;Marcus Sandri;Georg Fuernau

  • Ticagrelor with or without Aspirin in High-Risk Patients after PCI

    Roxana Mehran;Usman Baber;Samin K Sharma;David J Cohen

  • Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.

    Timo Mäkikallio;Niels R Holm;Mitchell Lindsay;Mark S Spence

  • Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk

    Philip Urban;Ian T Meredith;Alexandre Abizaid;Stuart J Pocock

  • Five-Year Outcomes with PCI Guided by Fractional Flow Reserve

    P. Xaplanteris;S. Fournier;N. H. J. Pijls;W. F. Fearon

  • Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

    Pascal Vranckx;Marco Valgimigli;Peter Jüni;Christian Hamm

  • Rescue Angioplasty after Failed Thrombolytic Therapy for Acute Myocardial Infarction

    Anthony H. Gershlick;Amanda Stephens-Lloyd;Sarah Hughes;Keith R. Abrams

  • Randomized Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Diabetic Patients: 1-Year Results of the CARDia (Coronary Artery Revascularization in Diabetes) Trial

    Akhil Kapur;Roger J. Hall;Roger J. Hall;Iqbal S. Malik;Ayesha C. Qureshi

  • Randomized Trial of Simple Versus Complex Drug-Eluting Stenting for Bifurcation Lesions. The British Bifurcation Coronary Study: Old, New, and Evolving Strategies

    David Hildick-Smith;Adam J. de Belder;Nina Cooter;Nicholas P. Curzen

  • Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial

    Lokien X van Nunen;Frederik M Zimmermann;Pim A L Tonino;Emanuele Barbato

  • Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial

    Thomas J. Ford;Bethany Stanley;Richard Good;Paul Rocchiccioli

  • Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.

    Daniel J F M Thuijs;A Pieter Kappetein;Patrick W Serruys;Friedrich-Wilhelm Mohr

  • Smoke-free legislation and hospitalizations for acute coronary syndrome

    Jill Pell;Sally Haw;Stuart M Cobbe;David E Newby

  • Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention

    William F. Fearon;Adrian F. Low;Andy S. Yong;Ross McGeoch

Frequent Co-Authors

Colin Berry
Colin Berry University of Glasgow
Mark C. Petrie
Mark C. Petrie University of Glasgow
Ian Ford
Ian Ford University of Glasgow
Alex McConnachie
Alex McConnachie University of Glasgow
Naveed Sattar
Naveed Sattar University of Glasgow
Bernard De Bruyne
Bernard De Bruyne Cardiovascular Center Aalst
Paul Welsh
Paul Welsh University of Glasgow
Nico H.J. Pijls
Nico H.J. Pijls Eindhoven University of Technology
William F. Fearon
William F. Fearon Stanford University
John P. Greenwood
John P. Greenwood University of Leeds

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens doors to a broad range of fulfilling pathways, many of which start with flexible online education options. If you're interested in preventive care and wellness, consider nutrition degrees online to gain specialized knowledge in dietetics and health promotion.

For those drawn to healthcare leadership, top cahme accredited mha programs offer advanced management skills essential for hospital and clinic administration roles.

Nursing professionals looking to upskill can find accelerated options via online rn to bsn no clinicals, a convenient way to broaden your practice and credentials without the need for extra clinical hours.

If your goal is to reach the highest levels of clinical practice, dnp programs online enable you to complete your Doctor of Nursing Practice efficiently and flexibly.

These online degrees not only offer convenience and accessibility, but also align with emerging healthcare demands—empowering you to advance your career without putting life on hold.

Best Scientists Citing Keith G. Oldroyd

Trending Scientists